Alterity Therapeutics Ltd: Appendix 4E Preliminary Final Report
Alterity Therapeutics Ltd: Notification of cessation of securities - ATH
Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Alterity Therapeutics Ltd: Alterity Therapeutics to Present at MST Financial Webinar
Alterity Therapeutics Ltd: Notice Under Section 708A
Alterity Therapeutics Ltd: Application for quotation of securities - ATH
Alterity Therapeutics Ltd: Proposed issue of securities - ATH
Alterity Therapeutics Ltd: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
Alterity Therapeutics Ltd: Trading Halt
Alterity Therapeutics Ltd: Notification regarding unquoted securities - ATH
Alterity Therapeutics Ltd: Alterity to Present at Hidden Gems in Life Sciences Webinar
Alterity Therapeutics Ltd: Webcast Today - New Data from bioMUSE Natural History Study
Alterity Therapeutics Ltd: Notification of cessation of securities - ATH
Alterity Therapeutics Ltd: Phase 2 DMC Recommends Continuing Clinical Trial as Planned
Alterity Therapeutics Ltd: Ceasing to be a substantial holder
Alterity Therapeutics Ltd: Change in substantial holding
Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Alterity Therapeutics Ltd: Application for quotation of securities - ATH
Alterity Therapeutics Ltd: Alterity Presents New Data on ATH434
Alterity Therapeutics Ltd: Change in substantial holding
No Data